# Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

> **NCT00924898** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 92 (actual)

## Conditions studied

- Acute HIV Infection
- HIV Infections

## Interventions

- **DRUG:** efavirenz, emtricitabine, and tenofovir

## Key facts

- **NCT ID:** NCT00924898
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2017-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924898, "Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00924898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*